Health‐related quality of life as an independent predictor of long‐term disability for patients with relapsing–remitting multiple sclerosis

Patient-reported baseline QoL levels provide additional prognostic information on MS disability beyond traditional clinical or sociodemographic factors. These findings reinforce the importance of incorporating a patient's evaluation of their own QoL level during patient monitoring and the assessment of treatment effects.